Kyung-Joon Kim

Title: Kyung-Joon Kim: Innovative Minds in Ophthalmology

Introduction: Kyung-Joon Kim, an accomplished inventor from Yongin-si, South Korea, has made significant contributions to the field of ophthalmology through his innovative eye drop formulation. With one patent to his name, he has demonstrated a commitment to improving treatments for conditions like macular degeneration.

Latest Patents: One of Kyung-Joon Kim’s notable inventions is a patent for eye drops in the form of a solution comprising a benzopyran derivative or pharmaceutically acceptable salt thereof. This formulation includes (2R,3R,4S)-6-amino-4-[N-(4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran. This invention is significant as it offers an eye drop formulation with excellent stability, a pH between 4.0 and 5.0, and a high concentration of the active ingredient for effective prevention and treatment of various eye conditions.

Career Highlights: Currently, Kyung-Joon Kim is affiliated with Hanlim Pharmaceutical Co., Ltd., where he continues to innovate and contribute to the development of pharmaceutical products. His work in creating stable and effective eye drop solutions showcases his expertise as an inventor in the competitive pharmaceutical field.

Collaborations: Throughout his career, Kyung-Joon Kim has worked alongside talented colleagues such as Dong-Yeop Shin and Hu-Seong Kim. Their collaboration reflects the synergy and teamwork essential for driving innovation in research and development within the pharmaceutical industry.

Conclusion: As an inventor, Kyung-Joon Kim exemplifies the impact that innovative formulations can have on enhancing patient care and treatment options. With his continued contributions to ophthalmology through patents and collaborations, he remains a key figure in the ongoing advancement of medical science.